Cigna signed a definitive agreement to acquire Express Scripts for $67 billion in cash and stock, including assumption of $15 billion in Express Scripts debt. Here are five things to know about the ...

A decision last year by a global health company opened a chasm that still separates thousands of patients from a community ...

Cigna's pharmacy benefit manager Express Scripts has filed a lawsuit against the FTC over the agency's recent report on PBMs, which highlighted their contribution to soaring drug prices in the U.S.

Cigna is following through on promises to more aggressively defend its pharmacy benefit manager. On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over the ...

(Reuters) – Hedge fund Glenview Capital Management on Thursday backed health insurer Cigna Corp’s deal to buy pharmacy benefit manager Express Scripts in the face of stiff opposition from activist ...

The billionaire investor Carl Icahn is not a fan of Cigna's plan to purchase the pharmacy benefit manager Express Scripts, a $67 billion deal that was announced in March. In a letter to Cigna ...

The insurer Cigna will spend about $52 billion to acquire the nation's biggest pharmacy benefit manager, Express Scripts, the latest in a string of proposed tie-ups as health care's bill payers ...

Express Scripts Inc. and health insurer Cigna Corp. have settled for a combined $27 million in a lawsuit brought by New York state related to contracts they had to provide pharmacy benefit management ...

Jennifer Jarvis helps take care of Central City’s park and veterans monument, but depends on her 20 medications – which she can no longer get filled at the local pharmacy in town, ...

Pharmacy benefit manager Express Scripts is fighting back against the ongoing Federal Trade Commission investigation into its industry's business practices. The Cigna division filed a lawsuit Tuesday ...

Cigna's pharmacy benefit manager business, Express Scripts, will exclude AbbVie's Humira from its largest commercial formularies. The wildly successful biologic drug for inflammatory conditions, such ...